ERLOTIB // Erlotinib PharmaSwiss 50 mg plėvele dengtos tabletės

Medicinal product

(Invented) name

Active substance (s)

Strength

Pharmaceutical form

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

Marketing authorisation holder

PharmaSwiss Česká republika s.r.o., Čekija

Date of authorisation

Date of renewal

Documents

Stage

Neregistruotas

Controlled?

Controlled substance type

Legal basis

10(1)

Procedure number

NL/H/3618/002/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up

Stadijos

Data	Stadija
	Neregistruotas